EMD Serono Research & Development Institute, Inc.
Quick facts
Marketed products
- Tecfidera · Immunology
Phase 3 pipeline
- Avelumab Weekly · Oncology
Avelumab is a human monoclonal antibody that blocks PD-L1, preventing its interaction with PD-1 and B7.1 receptors to reinvigorate anti-tumor immune responses. - Fluorouracil (5-FU) · Oncology
Fluorouracil is a pyrimidine analog that inhibits thymidylate synthase and gets incorporated into RNA and DNA, disrupting nucleotide synthesis and causing cancer cell death. - Rebif® new formulation (RNF) · Immunology
Rebif new formulation (RNF) is an interferon beta-1a used to treat multiple sclerosis.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: